Brain – Page 4 – MOSAEC

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

Alzheimer's Disease Biogen Inc Brain Clinical Trials donanemab Drugs (Pharmaceuticals) Eisai Co Ltd Eli Lilly and Company Food and Drug Administration Leqembi (Drug) Memory United States

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug

The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.

By Gina Kolata and Pam Belluck

Setback Deals Blow to Neuralink’s First Brain Implant Patient, but He Stays Upbeat

Brain Clinical Trials Computers and the Internet Disabilities Food and Drug Administration Implants Medical Devices Musk, Elon Neuralink Corp Paralysis Research Sensors

Setback Deals Blow to Neuralink’s First Brain Implant Patient, but He Stays Upbeat

Elon Musk’s first human experiment with a computerized brain device developed significant flaws, but the subject, who is paralyzed, has few regrets.

By Christina Jewett

Why Do People Make Music?

Brain internal-truncator Language and Languages Music Research

Why Do People Make Music?

In a new study, researchers found universal features of songs across many cultures, suggesting that music evolved in our distant ancestors.

By Carl Zimmer

Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimers

Brain Dementia Disease Rates Drugs (Pharmaceuticals) Genetics and Heredity Leqembi (Drug) Nature Medicine (Journal) Research

Study Suggests Genetics as a Cause, Not Just a Risk, for Some Alzheimers

People with two copies of the gene variant APOE4 are almost certain to get Alzheimer’s, say researchers, who proposed a framework under which such patients could be diagnosed years before symptoms.

By Pam Belluck